InflaRx IFRX
NASDAQ IFRX
$1.18 -0.03 (-2.48%)
At close: Nov 11, 2026 · 4:00 PM EST

InflaRx (IFRX) Amortization of Deferred Charges (2017 - 2018)

Updated

Analysis

InflaRx (IFRX) Amortization of Deferred Charges (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 InflaRx 87.47 Mn -324.65 Mn -27,031.55
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 515,266.22
Jun 30, 2018 70,413.22
Mar 31, 2018 2.69 Mn
Dec 31, 2017 2.85 Mn
Sep 30, 2017 997,628.71
Jun 30, 2017 925,820.53
Mar 31, 2017 866,175.81
API Access

InflaRx Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IFRX&period=max&api_key=YOUR_API_KEY